Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00478712 · ClinicalTrials.gov registry record
Hirschsprung Disease Genetic Study
A clinical trial of Hirschsprung Disease, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT00478712 is a study of Hirschsprung Disease that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 3,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00478712, a study of Hirschsprung Disease, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Hirschsprung disease is a genetic condition caused by lack of nerve cells in varying lengths of the intestines. This study will investigate the complex genetic basis of the disease, which involves multiple interacting genetic factors.
Conditions Studied
Interventions
- OTHER Identification of genetic causes of Hirschsprung Disease
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2001-01 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00478712
The ClinicalTrials.gov registry entry for NCT00478712 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hirschsprung Disease appearing as the primary indexed condition, and to 1 intervention - of which Identification of genetic causes of Hirschsprung Disease is the first listed.
NCT00478712 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00478712 about?
NCT00478712 is a clinical study titled "Hirschsprung Disease Genetic Study". Hirschsprung disease is a genetic condition caused by lack of nerve cells in varying lengths of the intestines. This study will investigate the complex genetic basis of the disease, which involves multiple interacting genetic factors.
What is the current status of trial NCT00478712?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2001-01. Estimated completion is 2028-12.
What conditions does trial NCT00478712 study?
This clinical trial studies the following conditions: Hirschsprung Disease.
What interventions are being tested in trial NCT00478712?
The interventions under investigation include: Identification of genetic causes of Hirschsprung Disease (OTHER).
Who is sponsoring clinical trial NCT00478712?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00478712 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hirschsprung Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.